Semen Baturaja (Persero) Tbk PT
IDX:SMBR
Semen Baturaja (Persero) Tbk PT
IDX:SMBR
Price:
206
IDR
-0.96%
Market Cap:
2T
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
SMBR Alert
Semen Baturaja (Persero) Tbk PT
206
-2 (-0.96%)
| 52 Week Range |
200
288
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Semen Baturaja (Persero) Tbk PT
Income Statement
Earnings Waterfall
Semen Baturaja (Persero) Tbk PT
Semen Baturaja (Persero) Tbk PT
|
Revenue
|
2T
IDR
|
|
Cost of Revenue
|
-1.5T
IDR
|
|
Gross Profit
|
547.6B
IDR
|
|
Operating Expenses
|
-329.2B
IDR
|
|
Operating Income
|
218.4B
IDR
|
|
Other Expenses
|
-115.1B
IDR
|
|
Net Income
|
103.2B
IDR
|
Income Statement
Semen Baturaja (Persero) Tbk PT
Semen Baturaja (Persero) Tbk PT
Currency: IDR
| Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||
| Revenue |
1 190 504
N/A
|
1 214 915
+2%
|
1 219 275
+0%
|
1 347 709
+11%
|
1 430 888
+6%
|
1 461 248
+2%
|
1 469 984
+1%
|
1 477 949
+1%
|
1 471 321
0%
|
1 522 808
+3%
|
1 553 221
+2%
|
1 498 232
-4%
|
1 479 522
-1%
|
1 551 525
+5%
|
1 617 964
+4%
|
1 707 693
+6%
|
1 924 300
+13%
|
1 995 808
+4%
|
2 024 329
+1%
|
2 045 755
+1%
|
2 047 278
+0%
|
1 999 517
-2%
|
1 912 547
-4%
|
1 837 877
-4%
|
1 725 901
-6%
|
1 721 907
0%
|
2 939 873
+71%
|
2 963 949
+1%
|
2 935 382
-1%
|
1 751 586
-40%
|
1 764 320
+1%
|
1 813 450
+3%
|
1 857 501
+2%
|
1 881 767
+1%
|
1 895 491
+1%
|
1 903 361
+0%
|
2 011 526
+6%
|
2 040 679
+1%
|
2 043 206
+0%
|
2 028 764
-1%
|
1 999 621
-1%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(806 029)
|
(835 736)
|
(839 476)
|
(884 577)
|
(942 383)
|
(967 669)
|
(987 312)
|
(999 441)
|
(996 388)
|
(1 011 810)
|
(1 026 386)
|
(991 825)
|
(968 555)
|
(1 078 707)
|
(1 125 554)
|
(1 187 056)
|
(1 346 736)
|
(1 289 163)
|
(1 261 131)
|
(1 242 080)
|
(1 186 698)
|
(1 124 628)
|
(1 082 990)
|
(1 062 437)
|
(992 540)
|
(1 001 749)
|
(1 696 881)
|
(1 673 938)
|
(1 653 395)
|
(975 520)
|
(992 860)
|
(1 015 989)
|
(1 037 222)
|
(1 112 848)
|
(1 096 001)
|
(1 161 663)
|
(1 311 616)
|
(1 397 190)
|
(1 438 038)
|
(1 443 707)
|
(1 452 020)
|
|
| Gross Profit |
384 475
N/A
|
379 179
-1%
|
379 799
+0%
|
463 132
+22%
|
488 504
+5%
|
493 579
+1%
|
482 671
-2%
|
478 507
-1%
|
474 933
-1%
|
510 998
+8%
|
526 836
+3%
|
506 408
-4%
|
510 968
+1%
|
472 818
-7%
|
492 410
+4%
|
520 637
+6%
|
577 564
+11%
|
706 645
+22%
|
763 198
+8%
|
803 675
+5%
|
860 580
+7%
|
874 889
+2%
|
829 557
-5%
|
775 440
-7%
|
733 361
-5%
|
720 158
-2%
|
1 242 993
+73%
|
1 290 012
+4%
|
1 281 987
-1%
|
776 066
-39%
|
771 459
-1%
|
797 461
+3%
|
820 278
+3%
|
768 919
-6%
|
799 489
+4%
|
741 698
-7%
|
699 910
-6%
|
643 490
-8%
|
605 168
-6%
|
585 057
-3%
|
547 602
-6%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(130 132)
|
(124 908)
|
(131 334)
|
(149 509)
|
(153 660)
|
(169 575)
|
(166 402)
|
(155 552)
|
(167 448)
|
(182 842)
|
(196 766)
|
(226 709)
|
(248 636)
|
(280 696)
|
(300 830)
|
(319 915)
|
(377 623)
|
(446 329)
|
(506 267)
|
(545 270)
|
(589 584)
|
(643 699)
|
(646 859)
|
(665 113)
|
(626 184)
|
(504 435)
|
(907 294)
|
(897 005)
|
(902 685)
|
(540 747)
|
(550 859)
|
(561 257)
|
(581 487)
|
(515 678)
|
(548 780)
|
(508 382)
|
(462 303)
|
(387 184)
|
(362 105)
|
(352 582)
|
(329 245)
|
|
| Selling, General & Administrative |
(131 730)
|
(126 771)
|
(133 417)
|
(146 504)
|
(148 811)
|
(154 764)
|
(152 244)
|
(140 972)
|
(154 957)
|
(183 423)
|
(201 057)
|
(231 357)
|
(251 520)
|
(275 666)
|
(289 200)
|
(306 753)
|
(366 362)
|
(427 095)
|
(496 123)
|
(526 159)
|
(561 340)
|
(595 870)
|
(591 750)
|
(605 634)
|
(573 790)
|
(497 399)
|
(869 454)
|
(864 263)
|
(857 712)
|
(526 883)
|
(484 995)
|
(493 506)
|
(501 097)
|
(467 225)
|
(504 651)
|
(480 067)
|
(451 976)
|
(395 827)
|
(372 445)
|
(354 957)
|
(338 823)
|
|
| Research & Development |
(929)
|
(2 147)
|
(1 121)
|
(2 057)
|
(2 069)
|
(3 342)
|
(3 571)
|
(3 023)
|
(2 406)
|
(1 287)
|
(959)
|
(634)
|
(813)
|
(1 183)
|
(854)
|
(1 450)
|
(1 238)
|
(1 122)
|
(1 393)
|
0
|
0
|
(3 038)
|
(572)
|
0
|
(917)
|
(2 070)
|
(663)
|
(836)
|
0
|
(675)
|
(539)
|
(555)
|
(1 019)
|
(231)
|
(687)
|
0
|
0
|
(329)
|
(85)
|
0
|
0
|
|
| Depreciation & Amortization |
(3 763)
|
(3 913)
|
(4 182)
|
(4 415)
|
(4 579)
|
(4 638)
|
(4 743)
|
(4 829)
|
(4 946)
|
(5 596)
|
(5 864)
|
(6 262)
|
(7 782)
|
(8 362)
|
(10 506)
|
(12 777)
|
(14 026)
|
(30 130)
|
(20 246)
|
(27 397)
|
(38 989)
|
(52 717)
|
(64 214)
|
(74 425)
|
(72 465)
|
(60 629)
|
(110 321)
|
(103 741)
|
(104 859)
|
(40 877)
|
(60 912)
|
(60 920)
|
(60 636)
|
(39 813)
|
(54 944)
|
(49 274)
|
(43 374)
|
(35 137)
|
(31 519)
|
(28 338)
|
(25 738)
|
|
| Other Operating Expenses |
6 291
|
7 923
|
7 387
|
3 469
|
1 801
|
(6 831)
|
(5 842)
|
(6 727)
|
(5 138)
|
7 464
|
11 114
|
11 543
|
11 478
|
4 514
|
(270)
|
1 067
|
4 003
|
12 018
|
11 494
|
8 286
|
10 745
|
7 926
|
9 677
|
14 947
|
20 988
|
55 664
|
73 144
|
71 835
|
59 886
|
27 688
|
(4 413)
|
(6 275)
|
(18 734)
|
(8 409)
|
11 502
|
20 959
|
33 046
|
44 110
|
41 944
|
30 713
|
35 316
|
|
| Operating Income |
254 344
N/A
|
254 272
0%
|
248 465
-2%
|
313 624
+26%
|
334 846
+7%
|
324 004
-3%
|
316 271
-2%
|
322 956
+2%
|
307 485
-5%
|
328 156
+7%
|
330 069
+1%
|
279 698
-15%
|
262 331
-6%
|
192 122
-27%
|
191 580
0%
|
200 722
+5%
|
199 941
0%
|
260 316
+30%
|
256 930
-1%
|
258 406
+1%
|
270 996
+5%
|
231 190
-15%
|
182 698
-21%
|
110 327
-40%
|
107 177
-3%
|
215 723
+101%
|
335 699
+56%
|
393 007
+17%
|
379 302
-3%
|
235 318
-38%
|
220 601
-6%
|
236 204
+7%
|
238 792
+1%
|
253 241
+6%
|
250 709
-1%
|
233 316
-7%
|
237 607
+2%
|
256 306
+8%
|
243 063
-5%
|
232 475
-4%
|
218 356
-6%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
145 933
|
150 538
|
153 047
|
151 246
|
134 840
|
119 410
|
75 954
|
49 836
|
35 652
|
21 124
|
18 824
|
12 151
|
505
|
16 761
|
(11 407)
|
(42 270)
|
(76 522)
|
(114 972)
|
(122 275)
|
(126 553)
|
(135 504)
|
(146 888)
|
(173 806)
|
(185 840)
|
(187 418)
|
(179 256)
|
(315 170)
|
(313 601)
|
(307 892)
|
(166 411)
|
(163 269)
|
(158 310)
|
(154 151)
|
(148 601)
|
(135 207)
|
(116 769)
|
(100 806)
|
(90 842)
|
(82 647)
|
(80 732)
|
(76 434)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
147
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(3)
|
0
|
(2)
|
(2)
|
(2)
|
0
|
4 360
|
5 824
|
6 725
|
0
|
4 945
|
4 928
|
5 042
|
64
|
4 911
|
4 716
|
4 862
|
12
|
4 282
|
4 272
|
4 498
|
2 270
|
6 502
|
5 202
|
4 806
|
0
|
931
|
2 849
|
1 862
|
0
|
1 862
|
0
|
0
|
(2 706)
|
91
|
91
|
91
|
(2 881)
|
(3 290)
|
(3 904)
|
(5 424)
|
|
| Pre-Tax Income |
400 274
N/A
|
404 810
+1%
|
401 510
-1%
|
464 868
+16%
|
469 684
+1%
|
443 414
-6%
|
396 585
-11%
|
378 616
-5%
|
349 862
-8%
|
349 281
0%
|
353 836
+1%
|
296 777
-16%
|
267 878
-10%
|
208 947
-22%
|
185 085
-11%
|
163 170
-12%
|
128 280
-21%
|
145 357
+13%
|
138 938
-4%
|
136 125
-2%
|
139 990
+3%
|
86 572
-38%
|
15 395
-82%
|
(70 311)
N/A
|
(75 435)
-7%
|
36 468
N/A
|
21 460
-41%
|
82 254
+283%
|
73 272
-11%
|
68 908
-6%
|
59 193
-14%
|
77 894
+32%
|
84 641
+9%
|
102 081
+21%
|
115 593
+13%
|
116 638
+1%
|
136 892
+17%
|
162 583
+19%
|
157 126
-3%
|
147 839
-6%
|
136 499
-8%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(69 400)
|
(68 855)
|
(67 446)
|
(84 473)
|
(90 213)
|
(89 234)
|
(87 842)
|
(89 520)
|
(85 607)
|
(90 190)
|
(91 007)
|
(79 668)
|
(75 988)
|
(62 299)
|
(57 822)
|
(52 954)
|
(48 279)
|
(69 282)
|
(71 402)
|
(76 582)
|
(82 080)
|
(56 498)
|
(53 619)
|
(44 802)
|
(29 820)
|
(25 486)
|
(40 941)
|
(43 599)
|
(45 668)
|
(22 202)
|
(15 802)
|
(12 952)
|
(6 285)
|
(24 763)
|
(20 621)
|
(20 961)
|
(31 268)
|
(41 011)
|
(40 170)
|
(35 577)
|
(33 273)
|
|
| Income from Continuing Operations |
330 875
|
335 955
|
334 065
|
380 396
|
379 471
|
354 180
|
308 745
|
289 098
|
264 257
|
259 091
|
262 830
|
217 110
|
191 891
|
146 648
|
127 263
|
110 216
|
80 001
|
76 075
|
67 536
|
59 543
|
57 910
|
30 074
|
(38 224)
|
(115 113)
|
(105 255)
|
10 982
|
(19 481)
|
38 656
|
27 603
|
46 706
|
43 391
|
64 942
|
78 356
|
77 318
|
94 972
|
95 677
|
105 624
|
121 573
|
116 956
|
112 263
|
103 226
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(6)
|
(4)
|
(4)
|
(4)
|
0
|
(5)
|
(6)
|
(7)
|
(7)
|
(3)
|
(2)
|
(0)
|
1
|
(2)
|
(0)
|
2
|
2
|
3
|
5
|
3
|
2
|
(2)
|
(1)
|
(1)
|
(1)
|
6
|
(0)
|
0
|
0
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Net Income (Common) |
330 875
N/A
|
335 955
+2%
|
334 065
-1%
|
380 396
+14%
|
379 471
0%
|
354 180
-7%
|
308 745
-13%
|
289 098
-6%
|
264 252
-9%
|
259 087
-2%
|
262 826
+1%
|
217 105
-17%
|
191 890
-12%
|
146 644
-24%
|
127 257
-13%
|
110 209
-13%
|
79 994
-27%
|
76 072
-5%
|
67 534
-11%
|
59 542
-12%
|
57 910
-3%
|
30 072
-48%
|
(38 225)
N/A
|
(115 111)
-201%
|
(105 253)
+9%
|
10 985
N/A
|
(19 476)
N/A
|
38 658
N/A
|
27 605
-29%
|
46 704
+69%
|
43 390
-7%
|
64 941
+50%
|
78 355
+21%
|
77 323
-1%
|
94 972
+23%
|
95 677
+1%
|
105 624
+10%
|
121 571
+15%
|
116 954
-4%
|
112 261
-4%
|
103 223
-8%
|
|
| EPS (Diluted) |
33.63
N/A
|
34.15
+2%
|
33.96
-1%
|
38.67
+14%
|
38.58
0%
|
36
-7%
|
31.39
-13%
|
29.39
-6%
|
26.86
-9%
|
26.34
-2%
|
26.71
+1%
|
22.06
-17%
|
19.5
-12%
|
14.84
-24%
|
12.93
-13%
|
11.2
-13%
|
8.13
-27%
|
7.66
-6%
|
6.79
-11%
|
5.99
-12%
|
5.83
-3%
|
3.03
-48%
|
-3.85
N/A
|
-11.59
-201%
|
-10.6
+9%
|
1.11
N/A
|
-1.96
N/A
|
3.89
N/A
|
2.78
-29%
|
4.7
+69%
|
4.37
-7%
|
6.54
+50%
|
7.89
+21%
|
7.78
-1%
|
9.56
+23%
|
9.63
+1%
|
10.63
+10%
|
12.24
+15%
|
11.77
-4%
|
11.3
-4%
|
10.39
-8%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
